Sodium/hydrogen‐exchanger‐2 modulates colonocyte lineage differentiation

Katerina Nikolovska(Medizinische Hochschule Hannover), Ursula Seidler(Medizinische Hochschule Hannover), Inga Viktoria Hensel(Medizinische Hochschule Hannover), Anurag Kumar Singh(National Institute of Technology Tiruchirappalli), Anna Seidler(Medizinische Hochschule Hannover), Brigitte Riederer(Medizinische Hochschule Hannover), Jiajie Qian(Medizinische Hochschule Hannover), Kunyan Zhou(Medizinische Hochschule Hannover), Gabriella Di Stefano(Medizinische Hochschule Hannover)
Acta Physiologica
January 5, 2022
10.1111/apha.13774
Cited by 11

Related Papers

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
|PLoS ONE|2007|478
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
|The Lancet|2021|452
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
|The Lancet|2017|449
Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II
|Science|1996|409